Do not implement referral-linked compensation without arrangement-specific federal and state review. Calling a payment a platform fee or marketing fee does not resolve its legal character.
HHS OIG explains that the federal Anti-Kickback Statute addresses knowing and willful remuneration intended to induce or reward business payable by federal healthcare programmes. (oig.hhs.gov)
Self-pay arrangements still require state analysis. For example, California Business and Professions Code section 650 addresses compensation or inducements for referrals by covered licensees, while distinguishing certain payments for actual non-referral services. (pharmacy.ca.gov)
Give counsel the complete payment map:
- Who pays whom, and for which documented service?
- Is payment linked to prescriptions, fills, revenue or patient volume?
- Are services actually performed and appropriately valued?
- Are federal programme patients or related services implicated?
- What ownership, exclusivity or steering arrangements exist?
- Which states and professional entities are involved?
For this research desk, keep supplier remuneration separate from editorial ranking and disclose any commercial relationship before an introduction.
Sources cited on this page
- oig.hhs.gov · Source 1 ↗https://oig.hhs.gov/compliance/physician-education/fraud-abuse-laws/?trk=article-ssr-frontend-pulse_little-text-block&utm_source=openai
- pharmacy.ca.gov · Source 2 ↗https://www.pharmacy.ca.gov/laws_regs/lawbook.pdf?preview=true&site_id=816